CO-TRITACE CO-TRITACE TRITACE TRITACE TRITACE TRIATEC HCT TRIATEC HCT RAMPRO RAMPRO RAMPRO RAMY RAMY RAMY RAMY RAMY PLUS RAMY PLUS RAMY PLUS MEVLON MEVLON MEVLON HIACE HIACE HIACE ADYTUM ADYTUM ADYTUM ADYTUM ADYTUM-H PREPACE PREPACE RAMIPACE D RAMIPACE D RAMIPACE RAMIPACE RAMIPACE RAMIPACE RAMIPACE RAMIPACE LIPRA LIPRA LIPRA LIPRA NORMIPIL NORMIPIL NORMIPIL NORMIPIL HYPERACE HYPERACE RAMRIL RAMRIL RAMRIL RAMITACE 3H RAMITACE 3H RAMITACE 3H B.P.ACE RAMISCOT RAMISCOT RAMIPROZ RAMIPROZ RAMIPRAZ RAMIPRAZ

Dose: 2.5 mg
Single Dose: 2.5 (2.5)
Frequency: 24 hourly
Route: PO
Instructions: Initially in 1-2 div.doses.

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

. It is of Synthetic origin and belongs to Phenylproplycarboxy acid. It belongs to Angiotensin converting enzyme inhibitor-ACEI pharmacological group on the basis of mechanism of action and also classified in Antihypertensive Agents pharmacological group.The Molecular Weight of Ramipril is 416.50. Its pKa is 3.1, 5.6.

Ramipril is contraindicated in conditions like Salt depletion,Hypotension,Arterial stenosis.

The severe or irreversible adverse effects of Ramipril, which give rise to further complications include Angioedema.Ramipril produces potentially life-threatening effects which include Renal failure, Hypotension. which are responsible for the discontinuation of Ramipril therapy.The signs and symptoms that are produced after the acute overdosage of Ramipril include Hypotension, Renal insufficiency.The symptomatic adverse reactions produced by Ramipril are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Diarrhea, Rashes, Nausea and vomiting.

Ramipril is primarily indicated in conditions like Benign gastric ulcer associated with H.pylori, Congestive heart failure (adjunct), Gastric acid reduction during anaesthesia, Heart failure, Hypertension, Iron deficiency anaemia, Mild to moderate hypertension, Prophylaxis of cardiovascular events/stroke.

Ramipril is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAlcoholAlprostadilEnhanced hypotensive effects when alprostadil given with ACE inhibitors (e.g Ramipril)IndomethacinLithiumTelmisartanWhen co-administering telmisartan and ramipril, the response may be greater because of the possibly additive pharmacodynamic effects of the combined drugs, and also because of the increased exposure to ramipril and ramiprilat in the presence of telmisartan.Moderate These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Tests for Renin Concentrations

Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Caps Store Below 40°C. Protect from Sunlight and Moisture.

Ramipril should be used with caution in patients with a history of angioedema, high blood levels of potassium, kidney disease or kidney dialysis, salt restrictive diet or liver disease. Consult the doctor before using salt substitutes or low salt milk. Get up slowly, to avoid dizziness and lightheadedness when rising from a seated or lying position. Limit intake of alcohol and use caution when exercising or during hot weather as these can aggravate dizziness and lightheadedness. It should be used only when clearly needed during the first three months of pregnancy, it is not recommended for use during the last six months of the pregnancy. Caution is advised when this is used in children and elderly.